Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E van den Akker-van Marle

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Allergy|January 14, 2005
Evaluation of cost of disease: assessing the burden to society of asthma in children in the European UnionM E van den Akker-van Marle, J Bruil, S B Detmar
Acta Ophthalmologica|June 25, 2022
Cost reduction in screening for retinopathy of prematurity in the Netherlands by comparing different screening strategiesKasia Trzcionkowska, Nicoline E Schalij-Delfos, Elske M E van den Akker-van Marle
British Journal of Cancer|April 3, 2003
Low risk of cervical cancer during a long period after negative screening in the NetherlandsM E van den Akker-van Marle, M van Ballegooijen, J D F Habbema
Gastroenterology|December 22, 2024
ReplyJ M Heijdra Suasnabar, M L Mearin, M E van den Akker-van Marle
BJOG : an International Journal of Obstetrics and Gynaecology|April 12, 2020
Challenges in economic evaluations in obstetric care: a scoping review and expert opinionS M Hulst, Wbf Brouwer, B W Mol, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 13, 2002
[Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996]A B Bos, M van Ballegooijen, M E van den Akker-van Marle, et al.
Allergy|May 7, 2005
Costs associated with persistent allergic rhinitis are reduced by levocetirizineJ Bousquet, N Demarteau, J Mullol, et al.
BMC Musculoskeletal Disorders|March 5, 2020
Study protocol for the DEFENDD trial: an RCT on the Dynamic Locking Blade Plate (DLBP) versus the Dynamic Hip Screw (DHS) for displaced femoral neck fractures in patients 65 years and youngerJ H Kalsbeek, W H Roerdink, P Krijnen, et al.
BMJ (Clinical Research Ed.)|July 3, 1999
Withdrawing low risk women from cervical screening programmes. Conclusions cannot yet be drawnM E van den Akker-van Marle, M van Ballegooijen, R Boer, et al.
British Journal of Cancer|January 1, 1997
Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectivenessM van Ballegooijen, M E van den Akker-van Marle, P G Warmerdam, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Allergy|January 14, 2005
Evaluation of cost of disease: assessing the burden to society of asthma in children in the European UnionM E van den Akker-van Marle, J Bruil, S B Detmar
Acta Ophthalmologica|June 25, 2022
Cost reduction in screening for retinopathy of prematurity in the Netherlands by comparing different screening strategiesKasia Trzcionkowska, Nicoline E Schalij-Delfos, Elske M E van den Akker-van Marle
British Journal of Cancer|April 3, 2003
Low risk of cervical cancer during a long period after negative screening in the NetherlandsM E van den Akker-van Marle, M van Ballegooijen, J D F Habbema
Gastroenterology|December 22, 2024
ReplyJ M Heijdra Suasnabar, M L Mearin, M E van den Akker-van Marle
BJOG : an International Journal of Obstetrics and Gynaecology|April 12, 2020
Challenges in economic evaluations in obstetric care: a scoping review and expert opinionS M Hulst, Wbf Brouwer, B W Mol, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 13, 2002
[Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996]A B Bos, M van Ballegooijen, M E van den Akker-van Marle, et al.
Allergy|May 7, 2005
Costs associated with persistent allergic rhinitis are reduced by levocetirizineJ Bousquet, N Demarteau, J Mullol, et al.
BMC Musculoskeletal Disorders|March 5, 2020
Study protocol for the DEFENDD trial: an RCT on the Dynamic Locking Blade Plate (DLBP) versus the Dynamic Hip Screw (DHS) for displaced femoral neck fractures in patients 65 years and youngerJ H Kalsbeek, W H Roerdink, P Krijnen, et al.
BMJ (Clinical Research Ed.)|July 3, 1999
Withdrawing low risk women from cervical screening programmes. Conclusions cannot yet be drawnM E van den Akker-van Marle, M van Ballegooijen, R Boer, et al.
British Journal of Cancer|January 1, 1997
Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectivenessM van Ballegooijen, M E van den Akker-van Marle, P G Warmerdam, et al.
Pageof 3